High levels of dopamine activity in the basal ganglia of cigarette smokers

被引:120
作者
Salokangas, RKR [1 ]
Vilkman, H
Ilonen, T
Taiminen, T
Bergman, J
Haaparanta, M
Solin, O
Alanen, A
Syvälahti, E
Hietala, J
机构
[1] Univ Turku, Cent Hosp, Dept Psychiat, FIN-20520 Turku, Finland
[2] Univ Turku, Cent Hosp, Dept Diagnost Radiol, FIN-20520 Turku, Finland
[3] Univ Turku, Dept Pharmacol & Clin Pharmacol, Turku, Finland
[4] Turku PET Ctr, Accelerator Lab, Turku, Finland
关键词
D O I
10.1176/appi.ajp.157.4.632
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The authors' goal was to study presynaptic dopamine activity in smoking and nonsmoking human subjects in vivo. Method: [F-18]Fluorodopa ([F-18]DOPA) uptake K-i values in the basal ganglia of nine smoking and 10 nonsmoking healthy men were measured with positron emission tomography Results: Significantly higher [F-18]DOPA uptake was observed in both the putamen (average 17.3% higher) and the caudate (average 30.4% higher) of smokers than in those of nonsmokers. Conclusions: Smoking is related to greater dopamine activity in the human basal ganglia. Nicotine-induced dopamine activity may be a relevant mechanism in dependence on cigarette smoking.
引用
收藏
页码:632 / 634
页数:3
相关论文
共 14 条
[1]  
Bergman J., 1994, Journal of Labelled Compounds and Radiopharmaceuticals, V35, P476
[2]   CIGARETTE-SMOKING AND NEUROLEPTIC-INDUCED PARKINSONISM [J].
DECINA, P ;
CARACCI, G ;
SANDIK, R ;
BERMAN, W ;
MUKHERJEE, S ;
SCAPICCHIO, P .
BIOLOGICAL PSYCHIATRY, 1990, 28 (06) :502-508
[3]   Inhibition of monoamine oxidase B in the brains of smokers [J].
Fowler, JS ;
Volkow, ND ;
Wang, GJ ;
Pappas, N ;
Logan, J ;
MacGregor, R ;
Alexoff, D ;
Shea, C ;
Schlyer, D ;
Wolf, AP ;
Warner, D ;
Zezulkova, I ;
Cilento, R .
NATURE, 1996, 379 (6567) :733-736
[4]   Brain monoamine oxidase A inhibition in cigarette smokers [J].
Fowler, JS ;
Volkow, ND ;
Wang, GJ ;
Pappas, N ;
Logan, J ;
Shea, C ;
Alexoff, D ;
MacGregor, RR ;
Schlyer, DJ ;
Zezulkova, I ;
Wolf, AP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14065-14069
[5]   Low CSF concentration of a dopamine metabolite in tobacco smokers [J].
Geracioti, TD ;
West, SA ;
Baker, DG ;
Hill, KK ;
Ekhator, NN ;
Wortman, MD ;
Keck, PE ;
Norman, AB .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (01) :130-132
[6]  
Glover V, 1980, J Neural Transm Suppl, P163
[7]   Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia [J].
Hietala, J ;
Syvälahti, E ;
Vilkman, H ;
Vuorio, K ;
Räkköläinen, V ;
Bergman, J ;
Haaparanta, M ;
Solin, O ;
Kuoppamäki, M ;
Eronen, E ;
Ruotsalainen, U ;
Salokangas, RKR .
SCHIZOPHRENIA RESEARCH, 1999, 35 (01) :41-50
[8]  
HUGHES JR, 1986, AM J PSYCHIAT, V143, P993
[9]   Smoking ... harmful to the brain [J].
Iversen, LL .
NATURE, 1996, 382 (6588) :206-207
[10]   DRUGS OF ABUSE - ANATOMY, PHARMACOLOGY AND FUNCTION OF REWARD PATHWAYS [J].
KOOB, GF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (05) :177-184